Stabilization of partially folded conformation during α-synuclein oligomerization in both purified and cytosolic preparations

被引:151
作者
Uversky, VN
Lee, HJ
Li, J
Fink, AL
Lee, SJ
机构
[1] Parkinsons Inst, Sunnyvale, CA 94089 USA
[2] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA
[3] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142292, Moscow Region, Russia
关键词
D O I
10.1074/jbc.C100551200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aggregation of alpha -synuclein is tightly associated with many neurodegenerative diseases, such as Parkinson's disease, dementia with Lewy body, Lewy body variant of Alzheimer's disease, multiple system atrophy, and Hallervorden-Spatz disease, implicating a crucial role of aggregated forms of alpha -synuclein in the pathogenesis. Here, we examined the effect of elevated temperature on the oligomerization and structural changes of alpha -synuclein in the early stage of aggregation and show that self-assembly is crucial for the stabilization of a partially folded conformation. The efficiency of alpha -synuclein oligomerization increased proportional to the temperature increase, both in purified form and in crude cytosolic preparation. This oligomerization coincided with a small but reproducible change in the circular dichroism spectrum and an increase in the 1-anilinonaphthalene-8-sulfonic acid binding. The hydrodynamic dimensions of the dimer measured by size exclusion chromatography suggest a pre-molten globule-like structure. These data suggest that partially folded alpha -synuclein, which is unstable in the monomeric form, is stabilized by self-assembly and that these oligomers may evolve into the fibril nucleus.
引用
收藏
页码:43495 / 43498
页数:4
相关论文
共 30 条
[1]  
Baba M, 1998, AM J PATHOL, V152, P879
[2]   Accumulation of insoluble α-synuclein in dementia with Lewy bodies [J].
Campbell, BCV ;
Li, QX ;
Culvenor, JG ;
Jäkälä, P ;
Cappai, R ;
Beyreuther, K ;
Masters, CL ;
McLean, CA .
NEUROBIOLOGY OF DISEASE, 2000, 7 (03) :192-200
[3]   The solubility of α-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease [J].
Campbell, BCV ;
McLean, CA ;
Culvenor, JG ;
Gai, WP ;
Blumbergs, PC ;
Jäkälä, P ;
Beyreuther, K ;
Masters, CL ;
Li, QX .
JOURNAL OF NEUROCHEMISTRY, 2001, 76 (01) :87-96
[4]   Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid [J].
Conway, KA ;
Harper, JD ;
Lansbury, PT .
BIOCHEMISTRY, 2000, 39 (10) :2552-2563
[5]   Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy [J].
Conway, KA ;
Lee, SJ ;
Rochet, JC ;
Ding, TT ;
Williamson, RE ;
Lansbury, PT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) :571-576
[6]   Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease [J].
Conway, KA ;
Harper, JD ;
Lansbury, PT .
NATURE MEDICINE, 1998, 4 (11) :1318-1320
[7]   A Drosophila model of Parkinson's disease [J].
Feany, MB ;
Bender, WW .
NATURE, 2000, 404 (6776) :394-398
[8]   Is there a cause-and-effect relationship between α-synuclein fibrillization and Parkinson's disease? [J].
Goldberg, MS ;
Lansbury, PT .
NATURE CELL BIOLOGY, 2000, 2 (07) :E115-E119
[9]   Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease [J].
Krüger, R ;
Kuhn, W ;
Müller, T ;
Woitalla, D ;
Graeber, M ;
Kösel, S ;
Przuntek, H ;
Epplen, JT ;
Schöls, L ;
Riess, O .
NATURE GENETICS, 1998, 18 (02) :106-108
[10]   Novel α-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease [J].
Langston, JW ;
Sastry, S ;
Chan, P ;
Forno, LS ;
Bolin, LM ;
Di Monte, DA .
EXPERIMENTAL NEUROLOGY, 1998, 154 (02) :684-690